Showing results (261-270 of 411) with videos related to

Sort By:
Pageof 42
Expert Review of Molecular Diagnostics|February 19, 2020
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseasesFilippo Baldacci, Sonia Mazzucchi, Alessandra Della Vecchia, et al.
Ageing Research Reviews|September 21, 2024
The role of parvalbumin interneuron dysfunction across neurodegenerative dementiasCarmelo Luca Smeralda, Siddhartha Pandit, Sonia Turrini, et al.
Current Alzheimer Research|December 20, 2014
Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State IndexAnette Hall, Jussi Mattila, Juha Koikkalainen, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 24, 2003
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's diseaseChristoph Hock, Alessia Maddalena, Andreas Raschig, et al.
Psychiatry Research|September 11, 2012
Association of microstructural white matter abnormalities with cognitive dysfunction in geriatric patients with major depressionGilberto Sousa Alves, Tarik Karakaya, Fabian Fußer, et al.
The American Journal of Psychiatry|February 4, 2003
Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231Katharina Buerger, Raymond Zinkowski, Stefan J Teipel, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 27, 2004
Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brainHarald Hampel, Andreas Haslinger, Michael Scheloske, et al.
Neurochemistry International|May 22, 2017
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's diseaseSimone Lista, Nicola Toschi, Filippo Baldacci, et al.
Pageof 42